Steven D. Ertel, SVP & Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,000 shares at $31.49 ($315K) on 2014-05-19, disclosed to the SEC on 2014-05-21.
Scheduled sale ($315k) by SVP & Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.48 | 7,109 | $224K | 71.0% |
| 2 | $31.49 | 2,400 | $76K | 24.0% |
| 3 | $32.19 | 391 | $13K | 4.0% |
| 4 | $32.35 | 100 | $3K | 1.0% |
| Total | $31.52 avg | 10,000 | $315K | 100% |
| Filing → |
| XLRN | SELL | 2016-04-08 | $1.0M | — | Filing → |
| XLRN | SELL | 2015-09-16 | $67K | — | Filing → |
| XLRN | SELL | 2015-08-19 | $61K | — | Filing → |